Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04879849
Title A Study of TAK-676 With Pembrolizumab After Radiation Therapy to Treat a Number of Cancers
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Takeda
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Cedars Sinai Medical Center Duarte California 91010-3012 United States Details
University of Chicago Chicago Illinois 60637-1443 United States Details
Laura And Isaac Perlmutter Cancer Center New York New York 10016-4744 United States Details
Providence Portland Medical Center Portland Oregon 97213-2933 United States Details
Vanderbilt University Medical Center Nashville Tennessee 37232-0021 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field